Pavan Cheruvu serves as Executive at Axovant Gene Therapies Ltd., where they oversee executive responsibilities. Since joining the company, Pavan Cheruvu has executed 8 insider transactions totaling $389.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 8, 2021 involved selling 14,884 shares valued at $21.1K.
Pavan Cheruvu currently holds 203,109 shares of Axovant Gene Therapies Ltd. (AXGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pavan Cheruvu has been a net buyer of AXGT stock. They have purchased $389.8K and sold $0 worth of shares.
Pavan Cheruvu's most recent insider trade was on Dec 8, 2021, when they sold 14,884 shares at $1.42 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 23, 2021 | SIOX | $248.0K | Purchase | 100,000 | $2.48 | Discretionary |
| Mar 17, 2021 | SIOX | $0 | Award | 22,590 | $N/A | Discretionary |
| Jul 8, 2020 | AXGT | $102.8K | Purchase | 37,500 | $2.74 | Discretionary |
| Jun 11, 2020 | AXGT | $30.1K | Payment | 9,755 | $3.09 | Discretionary |
| Jun 11, 2020 | AXGT | $0 | Award | 22,591 | $N/A | Discretionary |
| Jun 14, 2019 | AXGT | $39.1K | Purchase | 7,500 | $5.21 | Discretionary |